Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...
More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...
News-Medical.Net on MSN
Improving tobacco cessation care for people living with HIV
People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...
Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...
Ten years ago, the Indiana community of Austin made headlines for its historic HIV outbreak brought on by intravenous drug ...
Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback